Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment(*).
about
A Smartphone App to Screen for HIV-Related Neurocognitive ImpairmentAging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's DiseaseThe Montreal cognitive assessment to screen for cognitive impairment in HIV patients older than 60 years.Cognitive impairment in patients with AIDS - prevalence and severity.Screening for cognitive impairment in human immunodeficiency virus.A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need?Quantifying cognition at the bedside: a novel approach combining cognitive symptoms and signs in HIV.Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients.Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials.Assessing and treating forgetfulness and cognitive problems in adults with HIVExploring the utility of the Montreal Cognitive Assessment to detect HIV-associated neurocognitive disorder: the challenge and need for culturally valid screening tests in South Africa.Cognitive, emotion control, and motor performance of adolescents in the NCANDA study: Contributions from alcohol consumption, age, sex, ethnicity, and family history of addictionThe Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons.Canadian academy of geriatric psychiatry survey of brief cognitive screening instruments.Screening for Neurocognitive Impairment in HIV Individuals: The Utility of the Montreal Cognitive Assessment Test.Performance of a computer-based assessment of cognitive function measures in two cohorts of seniors.Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature.Applications of technology in neuropsychological assessment.Neurologic Complications and Considerations in HIV-Infected PersonsScreening for HIV-related neurocognitive impairment in clinical practice: challenges and opportunities.HIV-associated neurocognitive disordersCan a tablet-based cancellation test identify cognitive impairment in older adults?Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).Montreal Cognitive Assessment Performance in HIV/AIDS: Impact of Systemic Factors.The Montreal Cognitive Assessment: A Pilot Study of a Brief Screening Tool for Mild and Moderate Cognitive Impairment in HIV-Positive Veterans.Nonmedical treatment of patients with dementia.Limitations to the identification of HIV-associated neurocognitive disorders in clinical practice.Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.Utility of Using the Montreal Cognitive Assessment (MoCA) as a Screening Tool for HIV-Associated Neurocognitive Disorders (HAND) In Multi-Ethnic Malaysia.Effects of schooling on aspects of attention in rural Burkina Faso, West Africa
P2860
Q33440991-7201C92A-75AD-4574-8964-05185348D1E3Q33920647-19E30798-FB4E-4E31-9FD8-21D081E723B8Q34051545-0309F7BD-A186-4657-82D9-C8790011980CQ35057500-E316F37F-FB6E-4357-858E-47A1658FFAA1Q35215678-FAAF11AA-77DC-4CA3-896E-4ED9255E18A8Q35648919-D8A48006-19FA-4ACD-BA9C-39968AA841E8Q35840202-020D4569-7EEA-4CDE-B28A-27749F868397Q35878267-6D42FF81-B57B-4CB7-87E8-07580B93274DQ35893079-16EB962D-6BD9-4017-8F65-92D57E8BBE60Q36666859-9CC90E6B-4E94-4485-907E-67277D014CF2Q36781217-5007D058-9A51-4B84-9563-BCAF1287172EQ36823324-780A67FB-7D31-419F-9669-E094567FC557Q36849128-A85F8626-74BC-4C82-ADD8-3541B2217A8BQ36897717-E2A8F973-4442-43A1-95A2-9BBCF991B9EBQ37096724-B8F173D3-869E-47DF-B9CF-15D3F5C18767Q37179164-1F675292-0844-4D44-A8F1-46CE0358ED86Q37271765-303B4A38-119F-4FD9-8620-CF027E122182Q37407597-6682849A-CC55-4E29-A9E4-D636654EC17CQ38073190-6778551A-2B53-4654-A089-BD5AF7099179Q38122719-F4152F8C-38EB-4688-8A5A-11F783D1CF81Q38461834-EF2BE577-11D3-450B-9A05-DB587C9A8B9CQ40109294-7EFCED9C-9C6A-4CE5-8B57-84A62F5A9E91Q40674222-1EF73885-1ED8-41F7-A34D-EE4E0556DCCAQ40883557-5FD824B6-B5F2-487A-B003-38B1DBF9CEA5Q41610288-4EC31BBD-F311-4677-A313-12003263A1EBQ42176159-E0A1FEDC-E6DA-4E6F-9CFF-B8575F374A7FQ42266304-D5E3A535-F891-4A8D-9330-CB1AB5CDACC1Q44203354-94EAC7ED-B3BF-43BB-B28F-6704C1674713Q51557040-B7F44651-1439-4FC3-A186-827FCBFD4BFBQ56909640-0F6F0200-F0A3-462A-AD9F-1C70BB906248
P2860
Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment(*).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Computerized testing augments ...... ated mild cognitive impairment
@nl
Computerized testing augments ...... mild cognitive impairment(*).
@en
type
label
Computerized testing augments ...... ated mild cognitive impairment
@nl
Computerized testing augments ...... mild cognitive impairment(*).
@en
prefLabel
Computerized testing augments ...... ated mild cognitive impairment
@nl
Computerized testing augments ...... mild cognitive impairment(*).
@en
P2093
P2860
P1433
P1476
Computerized testing augments ...... d mild cognitive impairment(*)
@en
P2093
P2860
P304
P356
10.1111/J.1468-1293.2010.00910.X
P577
2011-03-13T00:00:00Z